SOURCE: SAFE-BioPharma Association

September 16, 2005 13:12 ET

Mollie Shields-Uehling of Safe-Biopharma Association to Participate in 15th Annual PDMA Sharing Conference

WHITEHOUSE STATION, NJ -- (MARKET WIRE) -- September 16, 2005 -- Mollie Shields-Uehling, president and chief executive officer of SAFE-BioPharma Association, an organization dedicated to managing the SAFE identity assurance standard for worldwide use by the healthcare industry, will be featured in a workshop, Tuesday, September 20, 2005 at the 15th Annual Prescription Drug Marketing Act (PDMA) Alliance Sharing Conference in Orlando, Florida. The workshop will orient PDMA compliance officers to the use of the SAFE identity assurance standard being adopted by the pharmaceutical and healthcare communities, and how it will reduce the cost and complexity of managing paper.

Organizations and companies participating in SAFE include the U.S. Food and Drug Administration (FDA), the European Medicines Evaluation Agency (EMEA), the National Cancer Institute (NCI), the Pharmaceutical Research and Manufacturers of America (PhRMA), Abbott Laboratories, Amgen, Astra-Zeneca, Bristol-Myers Squibb, Glaxo-Smith Kline, Johnson & Johnson, Merck, Pfizer, Procter and Gamble, Sanofi-Aventis, and TAP Pharmaceuticals.

About SAFE

SAFE (www.safe-biopharma.org) is an integral component of the global eHealth movement. It is an identity assurance standard that reduces the complexity and cost of managing paper for the healthcare community. SAFE digital signatures are being used in business-to-business and business-to-regulator transactions. SAFE signatures are legally enforceable and regulatory compliant.

Contact Information

  • For more information regarding SAFE, contact:
    Bree Clidence or Jill Anderson
    Stauch Vetromile & Mitchell
    401-490-9700
    Email Contact or Email Contact